Latest publications for May from Cochrane Infectious Diseases Group

During May 2021, we have published 2 new Cochrane reviews and one Cochrane review update in Issue 5, 2021 of the Cochrane Database of Systematic Reviews.

 New reviews

Haraka F, Kakolwa M, Schumacher SG, Nathavitharana RR, Denkinger CM, Gagneux S, Reither K, Ross A. Impact of the diagnostic test Xpert MTB/RIF on patient outcomes for tuberculosis. Cochrane Database of Systematic Reviews 2021, Issue 5. Art. No.: CD012972. DOI: 10.1002/14651858.CD012972.pub2. 

Anton-Vazquez V, Hine P, Krishna S, Chaplin M, Planche T. Rapid versus standard antimicrobial susceptibility testing to guide treatment of bloodstream infection. Cochrane Database of Systematic Reviews 2021, Issue 5. Art. No.: CD013235. DOI: 10.1002/14651858.CD013235.pub2

 Updated review

Gleave K, Lissenden N, Chaplin M, Choi L, Ranson H. Piperonyl butoxide (PBO) combined with pyrethroids in insecticide‐treated nets to prevent malaria in Africa. Cochrane Database of Systematic Reviews 2021, Issue 5. Art. No.: CD012776. DOI: 10.1002/14651858.CD012776.pub3.

Read the LSTM news article here 

The CIDG editorial base is located at the Liverpool School of Tropical Medicine  in Liverpool, UK. The CIDG is led by Professor Paul Garner (Co-ordinating Editor) and Deirdre Walshe (Managing Editor). Over 600 authors from some 52 countries contribute to the preparation of the Cochrane Reviews. They are supported by an international team of Editors, each with topic or methodological expertise. 

The CIDG’s main areas of work are on determination of the effects of interventions on the prevention or treatment infectious diseases of relevance to the  United Nations Sustainable Development Goals.